On the afternoon of July 30, 2020, Chen Shifei, Vice Minister of the State Drug Administration; Shao Yuanchang, Vice Director of Zhejiang Provincial Drug Administration; Yang Xiuqing, Vice Mayor of Lishui City; Liu Zhiwei, Secretary of the Party Working Committee and Director of the Management Committee of Lishui Economic and Technological Development Zone; Cao Yongyue, Deputy Secretary-General of Lishui Municipal Government; Xia Haiguo, Director of Lishui Municipal Market Supervision Bureau, and other officials visited Zhejiang Benefit Pharmaceutical for research and guidance. Wu Lihua, Chairman of the company, together with the senior management team, warmly received the delegation.

On behalf of all Benefit employees, Zhang Liyun, Administrative Director, extended a warm welcome to Minister Chen Shifei and his entourage for their research and guidance. She briefly introduced the company's overview, corporate culture, and the production process of the company's traditional Chinese medicine formula granules, and focused on reporting the company's strategic layout for the integrated development of the traditional Chinese medicine industry and the big health sector in the next five years.

Vice Minister Chen Shifei fully affirmed the achievements made by Benefit Pharmaceutical in recent years and the company's construction and layout ideas in the big health sector in the next five years. He stated that Lishui's favorable ecological environment and rich natural resources provide superior conditions for the traditional Chinese medicine industry. Benefit should effectively leverage the advantages of regional resources, adhere to the corporate mission of "Taking the Essence of Traditional Chinese Medicine, Promoting the Culture of National Quintessence", and accelerate the rapid development of Benefit's traditional Chinese medicine industry. The development of traditional Chinese medicine modernization has a long way to go, with both opportunities and challenges. It is hoped that Benefit will continue to explore new approaches and contribute to the inheritance and development of traditional Chinese medicine.